Novel Coronavirus vaccine (NOVEL coronavirus vaccine), a novel irus vaccine (NOVEL Coronavirus vaccine), developed by a team of Researchers from the University of Oxford, has been shown to induce a strong immune response without causing serious side effects.
The vaccine under evaluation is a chimpanzee adenovirus vector vaccine.
The team’s clinical trial in the UK involved 1077 healthy adults between the ages of 18 and 55 who had not been infected with novel Coronavirus.
According to the report, in this phase of the trial, the vaccine showed good safety, no serious side effects, some volunteers after inoculation of mild side effects are also manageable;
The vaccine induces a stronger immune response in two aspects of the body’s immune system — a T-cell response within 14 days of inoculation and an antibody response within 28 days.
Lead author Professor Andrew Pollard, of Oxford University, said the vaccine candidate was designed to induce the immune system to attack viruses and infected cells in two ways – antibodies and T-cell responses.
But Pollard said the team will need further clinical trials to see if the vaccine can effectively protect people from novel Coronavirus infection and how long the protection can last.
The team says they are currently conducting larger clinical trials of the vaccine in the UK, Brazil and South Africa.